In that sense, loss-of-function mutations in KEAP1 gene – leading to higher NRF2 activation – have been identified in several human adenocarcinoma, with lung cancer being the type where this gene is most mutated34. The gene discussed is NFE2L2; the disease is lung carcinoma.